Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil in ambulatory gynecologic laparoscopy
ChiCTR2500110643Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in perioperative pain (2 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoint: Incidence of cardiovascular depressive events. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on ChiCTR2500110643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110643.